Aclasta - 5mg Injection

Category: Drug Affecting Bone Metabolism
Manufacturer: Novartis
Composed of: Zoledronic Acid, Epirubicin
Used for: Osteoporosis,

Product Information

This medication is recommended in the management of osteoporosis (bone disorder in which the bones become extremely weak) in men and post-menopausal women.

Patients using this medication may at times experience headache, nausea, vomiting, and hypophosphatemia (decreased level of phosphates in blood). If you experience any of these symptoms for a long period of time, consult your doctor immediately.

This medication is not recommended in patients allergic to bisphosphonates.

Please consult your doctor before taking this medicine if you have any of these conditions; Hepatic or renal impairment (liver or kidney disorder) or any of the following stomach disorders like inflammatory bowel disorders, chronic ulcerations, intestinal obstructions, or chronic digestive or absorption problems.

Reviews & Comments

Disclaimer: All material on this website is provided for your information only and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. The data information and opinions expressed here are believed to be accurate, which is gathered from different sources but might have some errors. Hamariweb.com is not responsible for errors or omissions. Doctors and Hospital officials are not necessarily required to respond or go through this page.